Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Alpha-fetoprotein (AFP) is used as a tumor marker for hepatomas and germ cell tumors. In healthy non-pregnant adults the serum concentration (S-AFP) is very low and we examined whether it was affected when the acute phase response was activated, using patients with acute pelvic inflammatory disease (PID) as a model system. In 70 PID patients the median S-AFP was 1.2 kIU/l (range: 0.5-5.9 kIU/l), within the normal range. S-AFP did not correlate with the clinical grade of disease nor with the serum concentrations of acute phase reactants and albumin. Thus, S-AFP is not significantly affected by activation of the acute phase response and presence of infection should not per se interfere with the use of S-AFP as a tumor marker. However, a negative correlation was found with the serum concentration of alpha-2-macroglobulin (P = 0.05), but whether this has any biological significance remains to be clarified.
Christiansen
M
M
Department of Clinical Biochemistry, Statens Seruminstitut, Copenhagen, Denmark.
Høgdall
C K
CK
Brihmer
C
C
D000209:Acute-Phase Proteins / Q000032:analysis; D000210:Acute-Phase Reaction / Q000097:blood*; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001798:Blood Proteins / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000097:blood*; D000509:alpha-Fetoproteins / Q000032:analysis*
D000209:Acute-Phase Proteins; D001798:Blood Proteins; D000509:alpha-Fetoproteins